Top News: Bellicum Pharmaceuticals (NASDAQ:BLCM), Acasti Pharma Inc. (NASDAQ:ACST), First Financial Corp. (NASDAQ:THFF), Johnson & Johnson (NYSE:JNJ), International Business Machines (NYSE:IBM)

On Friday shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) closed at $23.02. Bellicum Pharma (NASDAQ:BLCM) announced that clinical results from a study conducted by the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist using the Company’s Caspase-9 safety switch (CaspaCIDe), were simultaneously published in BLOOD and featured today in a late-breaking oral presentation of the American Society of Gene and Cell Therapy (ASGCT) 18th Annual Meeting in New Orleans.

Acasti Pharma Inc. (NASDAQ:ACST) in last trading activity advanced 0.61% to close at $0.38. Company weekly performance is -6.76% while its quarterly performance stands at -13.11%. Acasti Pharma Inc. (NASDAQ:ACST) is -68.66% away from its 52 week high. It was reported on 11 May, that Acasti Pharma Inc. (NASDAQ:ACST) has now been given an additional 180 calendar days, until November 2, 2015, to regain compliance with the minimum $1.00 per share requirement for continued listing on the NASDAQ.

On last trading day First Financial Corp. (NASDAQ:THFF) decreased -0.71% to close at $33.78. Its volatility for the week is 1.85% while volatility for the month is 1.78%. THFF’s sales growth for past 5 years was -2.10% and its EPS growth for past 5 years was 8.10%. First Financial Corp. (NASDAQ:THFF) monthly performance is -3.90%. Zacks upgraded shares of First Financial Corp (NASDAQ:THFF) from a sell rating to a hold rating in a research note released on 11 May.

On Friday shares of Johnson & Johnson (NYSE:JNJ) closed at $102.30. Company’s sales growth for last 5 years was 3.70% and EPS growth for next 5 years is recorded as 5.13%. Johnson & Johnson (NYSE:JNJ) and Actavis plc (NYSE:ACT) have been cleared of any wrongdoing after being accused of not doing enough to warn patients of addiction risks posed by their prescription pain killers on sale. However, Purdue Pharma will have to make its case after a U.S District Court concluded it had a case to answer on the same issue.

International Business Machines Corporation (NYSE:IBM) in last trading activity fell -0.45% to close at $173.26. Company weekly performance is 0.34% while its quarterly performance stands at 8.83%. International Business Machines Corporation (NYSE:IBM) is -9.35% away from its 52 week high. International Business Machines Corporation (NYSE:IBM) has announced new servers, and storage software and solutions that it said would help more clients create hybrid cloud computing environments.

Leave a Reply

Your email address will not be published. Required fields are marked *